This content is restricted.
Brief
On March 13, 2025, Health Canada issued an update regarding Government of Canada signs bilateral agreement with Yukon for Drugs for Rare Diseases. The agreement invests over $8.5 million over three years to improve access to selected new drugs and existing treatments for rare diseases, including Yescarta for treating B-cell lymphomas in adults.
Highlights content goes here...
This content is restricted.

RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested